D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Donaldson
DCI
$10.8B
| $259K | ﹤0.01% |
3,739
-33,912
| -90% | -$2.28M |
|
3827
CALL
C.H. Robinson
CHRW
$22B
| $259K | ﹤0.01% |
2,700
-16,300
| -86% | -$1.53M |
|
3828
Stevanato
STVN
$5.37B
| $259K | ﹤0.01% |
10,600
-2,300
| -18% | -$52K |
|
3829
WisdomTree US MidCap Fund
EZM
$937M
| $259K | ﹤0.01% |
4,191
| – | – |
|
3830
CALL
Methanex
MEOH
$4.32B
| $258K | ﹤0.01% |
+7,800
| New | +$251K |
|
3831
Matrix Service
MTRX
$347M
| $258K | ﹤0.01% |
19,073
-20,960
| -52% | -$253K |
|
3832
Darling Ingredients
DAR
$9.93B
| $258K | ﹤0.01% |
+6,789
| New | +$223K |
|
3833
Leidos
LDOS
$14.1B
| $257K | ﹤0.01% |
1,632
-3,605
| -69% | -$533K |
|
|
SAFE
3834
CALL
Safehold
SAFE
$1.19B
| $257K | ﹤0.01% |
+16,500
| New | +$256K |
|
3835
CALL
Symbotic
SYM
$5.11B
| $256K | ﹤0.01% |
6,600
-6,700
| -50% | -$175K |
|
3836
Spok Holdings
SPOK
$221M
| $256K | ﹤0.01% |
+14,499
| New | +$234K |
|
|
IPCX
3837
Inflection Point Acquisition Corp III
IPCX
$359M
| $256K | ﹤0.01% |
+25,000
| New | +$255K |
|
3838
PUT
Cogent Communications
CCOI
$594M
| $256K | ﹤0.01% |
+5,300
| New | +$269K |
|
3839
PUT
Ameresco
AMRC
$1.15B
| $255K | ﹤0.01% |
+16,800
| New | +$220K |
|
3840
Taylor Devices
TAYD
$175M
| $255K | ﹤0.01% |
+5,877
| New | +$209K |
|
3841
AtriCure
ATRC
$1.77B
| $255K | ﹤0.01% |
7,776
-17,579
| -69% | -$571K |
|
3842
PUT
Eldorado Gold
EGO
$8.31B
| $254K | ﹤0.01% |
+12,500
| New | +$243K |
|
3843
MBIA
MBI
$288M
| $254K | ﹤0.01% |
58,542
-27,640
| -32% | -$123K |
|
|
CBL
3844
CBL Properties
CBL
$1.78B
| $253K | ﹤0.01% |
9,982
-5,506
| -36% | -$136K |
|
3845
CALL
BRC Group Holdings
RILY
$277M
| $252K | ﹤0.01% |
85,000
| – | – |
|
3846
Structure Therapeutics
GPCR
$3.49B
| $252K | ﹤0.01% |
12,165
+504
| +4% | +$11.1K |
|
3847
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$258M
| $252K | ﹤0.01% |
6,050
| – | – |
|
3848
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $250K | ﹤0.01% |
+5,913
| New | +$236K |
|
3849
Inspired Entertainment
INSE
$177M
| $250K | ﹤0.01% |
30,554
+13,722
| +82% | +$106K |
|
3850
Dimensional US Large Cap Value ETF
DFLV
$6.69B
| $250K | ﹤0.01% |
+8,045
| New | +$238K |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.